View |
|
DR-XY48736
|
Pomalidomide
|
Pomalid 2
|
2 mg
|
Capsules
|
-
|
Natco Pharma Limited - Pharma Division (Unit IV and V)
|
India
|
Monitored Release
|
19 May 2023
|
19 May 2028
|
View |
|
DR-XY48735
|
Pomalidomide
|
Pomalid 3
|
3 mg
|
Capsule
|
-
|
Natco Pharma Limited - Pharma Division (Unit IV and V)
|
India
|
Monitored Release
|
17 May 2023
|
19 May 2028
|
View |
|
DRP-5240-20
|
Ceftriaxone (as sodium)
|
Gentriaxone
|
1 G
|
Powder For Injection (Im/Iv)
|
Antibacterial (Cephalosporin)
|
SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATION LTD.
|
India
|
Renewal
|
19 April 2024
|
07 April 2029
|
View |
|
DRP-9340-01
|
Ampicillin (as Sodium) + Sulbactam (as Sodium)
|
RAVITAM
|
1 g/500 mg
|
Powder For Injection (I.M/I.V)
|
Antibacterial (Penici11in/Beta-lactamase Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
09 March 2024
|
27 December 2028
|
View |
|
DRP-8584-06
|
Pantoprazole (As Sodium Sesquihydrate) + Domperidone
|
Pantomide
|
40 mg / 30 mg
|
Modified-Release Capsule
|
-
|
Theon Pharmaceuticals Limited
|
India
|
Initial (CLIDP)
|
31 August 2021
|
18 December 2024
|
View |
|
DRP-10640
|
Fusidic Acid
|
Fusmed
|
20 mg/g (2% w/w)
|
Ointment
|
-
|
Saludcare (1) Pvt. Ltd.
|
India
|
Initial
|
02 November 2021
|
02 November 2026
|
View |
|
DRP-10655
|
Paracetamol + Phenylpropanolamine HC1
Chlorphenamine maleate
|
None
|
500 mg/25 mg/2 mg
|
Tablet
|
Analgesic-Antipyretic/Nasal
Decongestant/Antihistamine
|
Am-Europharma Corporation
|
Philippines
|
Initial
|
02 November 2021
|
02 November 2026
|
View |
|
DRP-10638
|
Zinc
|
Kinzee
|
20 mg (equivalent to 54.89 mg Zinc Sulfate
Monohydrate)
|
Dispersible Tablet
|
Mineral
|
Medicamen Biotech Limited
|
India
|
Initial
|
02 November 2021
|
02 November 2026
|
View |
|
DRP-10639
|
Paracetamol
|
Pyresaph
|
500 mg
|
Tablet
|
Analgesic/Anti-Pyretic
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
02 November 2021
|
02 November 2026
|
View |
|
DRP-11154
|
Nicardipine Hydrochloride
|
Blinic
|
1mg/mL (10mg/10mL)
|
Solution For Injection (IV Infusion)
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
Makcur Laboratories Limited
|
India
|
Initial
|
11 February 2022
|
11 February 2027
|
View |
|
DRP-11228
|
Paracetamol
|
None
|
120 mg/5 mL
|
Suspension (Orange Flavor)
|
Analgesic/ Antipyretic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial [OTC] (Correction)
|
27 June 2024
|
15 February 2027
|
View |
|
DR-XY47221
|
Gabapentin
|
Gaba 300
|
300mg
|
Capsule
|
-
|
Unison Laboratories Co., Ltd.
|
Thailand
|
Initial
|
22 February 2022
|
27 April 2026
|
View |
|
DR-XY47143
|
Loratadine
|
None
|
10mg
|
Tablet
|
-
|
Cadila Pharmaceuticals Limited
|
India
|
Initial
|
12 January 2021
|
12 January 2026
|
View |
|
DRP-10279
|
Atorvastatin (as calcium)
|
Retorvast
|
80mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Sydenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
01 September 2021
|
17 April 2025
|
View |
|
DR-XY47710
|
Mupirocin
|
Mupibro
|
20 mg/g (2% w/w)
|
Ointment
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
07 February 2022
|
07 February 2025
|
View |
|
DRP-11202
|
Sitagliptin (as phosphate monohydrate)
|
None
|
25 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
11 February 2022
|
11 February 2027
|
View |
|
DRP-11201
|
Sitagliptin (as Phosphate monohydrate)
|
None
|
25 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
11 February 2022
|
11 February 2027
|
View |
|
DRP-11200
|
Sitagliptin (as Phosphate monohydrate)
|
None
|
25 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
11 February 2022
|
11 February 2027
|
View |
|
DR-XY47648
|
Salbutamol(as sulfate) + Ipratropium Bromide
|
Iprax-Mol
|
2.5 mg + 500 mcg
|
SOLUTION FOR INHALATION
|
Beta2-adrenergic agonist/anticholinergic combination
|
Axa Parenterals Limited
|
India
|
Initial
|
07 January 2022
|
07 January 2027
|
View |
|
DRP-9781
|
Carbocisteine
|
Diacof
|
500mg
|
Capsule
|
-
|
Diamond Laboratories, Inc.
|
Philippines
|
PCPR
|
03 June 2021
|
01 December 2025
|